Ledger. Australian venture funding, tracked

Startup · $23m raised · Healthcare

Infensa Bioscience

Biotech startup

Brisbane, QLD

Coverage

Stories naming Infensa Bioscience. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

17 deals

CTV Funding News - July 2022

Cut Through Venture's August update rounds up July 2022 Australian startup funding, listing raises from Mx51 to WeMoney, Startmate's newest cohort of twelve, and the beta launch of its investor search tool.

Cut Through Venture 1 Aug 2022 AndromedaBlendAIButter InsuranceCipher Sports TechnologyCloutlyDextaFemmi CoFinspoFuturerentHiveryHumanInDebtedInfensa BioscienceInternMatchMx51PearlerRefundidSidekickerSoundSmithStoripressTuteroUpcoverWeMoneyWrivetedCanvaCut Through VentureUniversity of QueenslandAcorn CapitalAntler AustraliaAS1 PartnersBlackbird VenturesCarthona CapitalCommencer CapitalMassMutual VenturesMastercardOneVenturesPerennial Private InvestmentsRampersandStartmateTiger GlobalChris GillingsVictor Zheng

Also Techboard

Unnamed stage $23m

Biotech startup using funnel-web spider venom to treat heart attacks raises $23 million

Brisbane biotech Infensa Bioscience raised $23 million to develop a heart-attack and stroke treatment derived from funnel-web spider venom, after spinning out of the University of Queensland.

Startup Daily 4 Jul 2022 Infensa BioscienceMonash UniversityUniQuestUniversity of QueenslandVictor Chang Cardiac Research InstituteGlenn KingMark SmytheDr Nathan PalpantPeter MacdonaldRob Widdop

Also Cut Through Venture·SmartCompany

Something wrong? Tell us